title: Successful single-cycle rituximab treatment in a patient with pemphigus vulgaris and squamous cell carcinoma of the tongue and IgG antibodies to desmocollins.
authors.affiliation: Department of Dermatology, St George Hospital, Sydney, Australia.
authors.forename: Jaehwan
authors.initials: J
authors.lastname: Kim
authors.forename: Kwesi
authors.initials: K
authors.lastname: Teye
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Koga
authors.forename: Sue-Ching
authors.initials: SC
authors.lastname: Yeoh
authors.forename: Denis
authors.initials: D
authors.lastname: Wakefield
authors.forename: Takashi
authors.initials: T
authors.lastname: Hashimoto
authors.forename: Dedee F
authors.initials: DF
authors.lastname: Murrell
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000188:drug therapy*; D051187:Desmocollins / Q000276:immunology / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010392:Pemphigus / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D000077195:Squamous Cell Carcinoma of Head and Neck; D014062:Tongue Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D051187:Desmocollins; D007074:Immunoglobulin G; D000069283:Rituximab